Drugs / VG101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00453089 | Jun 2012 → Jun 2013 | postmenopausal atrophic vaginitis, vulvar dystrophy | Bionovo | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VG101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00453089 ↗ |